DELIVER Study: DELiverability of the Resolute Integrity Stent in All-Comer Vessels and Cross-OvER Stenting

Medtronic

Status: Completed

Conditions: Coronary Artery Disease

Treatments: Device: Stent implantation

Study type: Observational

Funder types: Industry

Identifiers

NCT01297257

IP992

Details and patient eligibility

About

The primary objective of the DELIVER Study is to assess the deliverability of the Resolute Integrity Stent as primary stent or as a secondary cross-over stent following delivery failure of another stent type in real world patients.

Enrollment: 7,845 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Minimum legal age (18)
• Acceptable candidate for treatment with a drug-eluting stent in accordance with applicable guidelines
• Patient has consented to participate and authorized in writing the collection and release of medical information

Exclusion criteria

• Pregnancy
• Participating in another study that interferes with study endpoints
• Untreatable hypersensitivity or allergies to aspirin, heparin, clopidogrel, zotarolimus or similar drugs or contrast media
• Patients in whom anti-platelet and/or anticoagulation therapy is contraindicated